Status:
COMPLETED
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Interstitial Cystitis
Eligibility:
All Genders
19-65 years
Phase:
PHASE4
Brief Summary
Anecdotal evidence suggests female patients with painful bladder disorder interstitial cystitis (IC) can experience a significant attenuation of their systems while breastfeeding. Since it has been sh...
Detailed Description
Fifty patients will be enrolled in a double-blinded, placebo-controlled single-dose crossover trial comparing intranasal oxytocin to intranasal saline. At the time of enrollment, patients will complet...
Eligibility Criteria
Inclusion
- 19 - 65 years of age
- Must meet the current National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) diagnostic criteria for interstitial cystitis and have some degree of continuous daily pain
Exclusion
- Pregnancy
- Under the age of 19
- Older that the age of 65
- Breastfeeding women
- Uncontrolled hypertension
- History of significant cardiac or pulmonary disease (including arrhythmias)
- Known allergy to oxytocin
- Severe psychiatric disease
- Patients who have undergone procedural interventions within the past month related to their interstitial cystitis
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00919802
Start Date
June 1 2010
End Date
September 1 2015
Last Update
May 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294